14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:DMTX
Delisted

Dimension Therapeutics Fund Forecast

$5.95
+0 (+0%)
At Close: Jan 16, 2018
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Dimension Therapeutics Fund and on which exchange is it traded?
The symbol for Dimension Therapeutics is DMTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Dimension Therapeutics Fund?
Dimension Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Dimension Therapeutics Fund?
Dimension Therapeutics Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Dimension Therapeutics Fund.

What's the current price of Dimension Therapeutics Fund?
As of the end of day on the Jan 16, 2018, the price of an Dimension Therapeutics (DMTX) share was $5.95.

What is the 52-week high and low for Dimension Therapeutics Fund?
The 52-week high for Dimension Therapeutics Fund is $6.10 and the 52-week low is $1.05.
Click to get the best stock tips daily for free!

About Dimension Therapeutics

Dimension Therapeutics, Inc., a gene therapy platform company, focuses on discovering and developing therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations. The company's pipeline of programs includes DTX101, a lead gene therapy product candidate designed to deliver Factor IX, gene expression in patients with hemophilia B; DTX201, a gene therapy program for the treatment of hemophilia A... DMTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT